Acilac side effects by duration, gender and age - a phase IV clinical study of FDA data


Side effects are reported by people who take Acilac. Common side effects include metastatic neoplasm among females and abdominal pain among males.

The phase IV clinical study is created by eHealthMe based on 3 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jul, 03, 2022

3 people who take Acilac and have side effects are studied.

What is Acilac?

Acilac has active ingredients of lactulose. eHealthMe is studying from 4 Acilac users for its effectiveness, alternative drugs and more.

Number of Acilac reports submitted per year:

Acilac side effects.

Acilac side effects by gender *:


  1. Metastatic neoplasm (spreadable cancer tumour)


  1. Abdominal pain

Acilac side effects by age (0-1 to 60+) *:
















  1. Metastatic neoplasm (spreadable cancer tumour)

* Approximation only. Some reports may have incomplete information.

Do you take Acilac?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on lactulose (the active ingredients of Acilac) and Acilac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Acilac:

All Acilac side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: